Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Jan 27, 2023; 15(1): 72-81
Published online Jan 27, 2023. doi: 10.4240/wjgs.v15.i1.72
Published online Jan 27, 2023. doi: 10.4240/wjgs.v15.i1.72
Table 1 Preoperative and clinical characteristics of elderly patients with hepatocellular carcinoma with a body mass index < 30 or ≥ 30 who underwent laparoscopic liver resection
| LLR before PSM (224) | After PSM (54) | |||||
| BMI < 30 (196) | BMI ≥ 30 (28) | P | BMI < 30 (27) | BMI ≥ 30 (27) | P | |
| MALE | 135 (69) | 26 (93) | 0.00 | 17 | 25 | 0.02 |
| Age (yr), median (range) | 75.2 (69.5-90.0) | 75.3 (69.7-86.6) | 0.70 | 76.3 (70.6-81.2) | 73.1 (70-82.3) | 0.70 |
| BMI (kg/cm²), median (range) | 26.7 (19.0-29.0) | 32.5 (30.0-52.0) | 0.00 | 26.7 (25.0-267.0) | 33 (30-37) | |
| Co-morbidities > 2, n (%) | 77 (80) | 9 (32) | 0.50 | 14 | 9 | 0.27 |
| Cause of Cirrhosis, n (%) | ||||||
| Hepatitis C virus | 102 (52) | 12 (43) | 0.40 | 16 | 11 | 0.27 |
| Hepatitis B virus | 39 (20) | 4 (14) | 0.60 | 7 | 4 | 0.50 |
| Alcohol | 23 (12) | 7 (25) | 0.07 | 1 | 7 | 0.05 |
| Others | 32 (16) | 5 (18) | 0.80 | 3 | 5 | 0.70 |
| ASA score, n (%) | 0.80 | 1.00 | ||||
| I-II | 84 (43) | 11 (39) | 10 | 10 | ||
| III-IV | 112 (57) | 17 (61) | 17 | 17 | ||
| Blood tests median (range) | ||||||
| Bilirubin (mg/dL) | 0.9 (0.2-4.2) | 0.9 (0.2-2.1) | 0.8 | 0.9 (0.3-1.1) | 0.5 (0.2-1.1) | 0.70 |
| Creatinine (mg/dL) | 0.9 (0.2-2.5) | 0.9 (0.4-1.9) | 1.00 | 0.9 (0.8-1.5) | 0.9 (0.7-2) | 0.80 |
| Platelet count, × 109/L | 176 (45-421) | 187 (72-468) | 0.3 | 144 (47-337) | 168 (117-396) | 0.80 |
| INR | 1.1 (0.6-2.0) | 1.08 (0.7-1.67) | 0.3 | 1.1 (1-1.5) | 1 (1-1.3) | 0.50 |
| CHILD-PUGH, n (%) | 0.2 | 1.00 | ||||
| A | 177 (90) | 23 (82) | 23 | 22 | ||
| B | 19 (68) | 5 (18) | 4 | 5 | ||
| MELD median (range) | 6 (6-16) | 6 (6-13) | 0.6 | 8 (6-12.5) | 8 (6-13) | 0.40 |
| Tumors number n (%) | 0.06 | 1.00 | ||||
| Single nodule | 191 (97) | 25 (89) | 24 | 24 | ||
| Multi nodules | 5 (3) | 3 (11) | 3 | 3 | ||
| Tumors size (mm), median (range) | 30 (9-50) | 30 (18-50) | 0.6 | 30 (9-50) | 27 (24-35) | 0.30 |
| Bilobar tumor, n (%) | 1 (0.5) | 1 (3) | 0.2 | 1 | 1 | 1.00 |
| Tumor in PS segment, n (%) | 41 (21) | 6 (21) | 1.00 | 5 | 5 | 1.00 |
| Histologically proven n (%) | 31 (16) | 8 (29) | 0.11 | |||
| Previous treatment, n (%) | 12 (6) | 3 (10) | 0.4 | |||
| Major hepatectomy, n (%) | 22 (11) | 2 (7) | 0.7 | 1 | 2 | 1.00 |
| Operative time > 240 min | 73 (37) | 12 (43) | 0.7 | 150 (80-210) | 150 (65-155) | 0.70 |
- Citation: Conticchio M, Inchingolo R, Delvecchio A, Ratti F, Gelli M, Anelli MF, Laurent A, Vitali GC, Magistri P, Assirati G, Felli E, Wakabayashi T, Pessaux P, Piardi T, di Benedetto F, de’Angelis N, Briceño J, Rampoldi A, Adam R, Cherqui D, Aldrighetti LA, Memeo R. Impact of body mass index in elderly patients treated with laparoscopic liver resection for hepatocellular carcinoma. World J Gastrointest Surg 2023; 15(1): 72-81
- URL: https://www.wjgnet.com/1948-9366/full/v15/i1/72.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i1.72